CONMED Sees FY24 Adj. EPS $4.25-$4.35 Vs $4.33 Est.; Revenue $1.330B-$1.355B Vs $1.350B Est.
Portfolio Pulse from Benzinga Newsdesk
CONMED projects its FY24 adjusted EPS to be between $4.25 and $4.35, compared to the estimated $4.33. The company also forecasts revenue to be in the range of $1.330 billion to $1.355 billion, against an estimate of $1.350 billion.

April 24, 2024 | 8:42 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
CONMED's FY24 earnings and revenue projections are closely aligned with analyst estimates, indicating stable financial expectations.
CONMED's projected adjusted EPS and revenue for FY24 are very close to analyst estimates, suggesting that the company's financial performance is expected to be stable. This alignment with expectations indicates neither a significant positive nor negative surprise to the market, hence the neutral score. The high relevance reflects the direct impact of these projections on CONMED's financial outlook, while the importance is marked high due to the significance of earnings and revenue forecasts in investor decision-making. The confidence level is set at 85, acknowledging the precision of the projections but also considering the inherent uncertainties in forecasting.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90